PHARMACEUTICAL CARE IN VITAMIN D PROVISION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

After the pandemic, both in Georgia and around the world, the human immune system is affected. Modern studies have established that the risk of developing type 2 diabetes increases with vitamin D deficiency. According to one study, obese patients without diabetes had relatively higher levels of vitamin D than diabetic patients.

Today, the role of vitamin D in the prevention of the development of diabetes is highlighted due to its immunomodulatory action. As we learned from the literature data, the risk of developing diabetes increases when there is a lack of vitamin C in the body.

  Obese patients who do not have diabetes have relatively high levels of vitamin D, which once again confirms the need for vitamin D supplementation. Vitamin D belongs to fat-soluble sequosteroids. Its two forms are most important for humans: vitamin D3 - cholecalciferol, which is produced in the skin by exposure to ultraviolet rays of the sun, and vitamin D2 - ergocalciferol, which enters the body with the help of various types of food.

Vitamin D regulates the function of more than 200 genes. It affects:

• on the immune system (body's defense mechanisms)
• On the absorption of calcium, magnesium, zinc, phosphate and iron from the intestine
• On the proper functioning of the bone-joint system
• on the normal functioning of the nervous system

Accordingly, in the development of diabetes. At the initial stage of diabetes, patients must receive microelements and amino acids. And for the correct and rational appointment of the latter, it is necessary to study the peculiarities of the protein and mineral metabolism of each patient.

An important role is played by vitamin D in the regulation of phosphorus-calcium and, therefore, in the metabolism in bone tissue, although many people do not know that vitamin D and calcium have a significant effect on: autoimmune diseases, atherosclerosis, obesity, cardiovascular diseases, diabetes mellitus, etc. on conditions such as insulin resistance (resistance) oncological pathologies.